Nycomed to Use Genedata's Screener Software for HTS in Rx Programs | GenomeWeb
NEW YORK (GenomeWeb News) - Genedata said today it has extended a contract with Nycomed for its Genedata Screener software in pharmaceutical development projects.
 
Screener will enable Nycomed’s researchers to “rapidly capture, visualize, analyze, and manage large volumes of assay data,” Genedata said in a statement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.